Search

everythinglearnresearchcommunity

for

Search:↓

Certain immune cells contribute to severe hair loss in chronic alopecia areata, with Th17 cells possibly having a bigger impact than cytotoxic T cells.

The document concludes that Cutaneous Lupus Erythematosus has different forms, is influenced by genetic and environmental factors, and can be treated with various medications, but more targeted therapies are needed.

iNKT cells can help prevent and treat alopecia areata by promoting hair regrowth.

Autoimmune and inflammatory processes are involved in both scarring and non-scarring types of hair loss.

Toxic Epidermal Necrolysis is a rare, serious skin condition that can affect anyone, is more common in women, and may be linked to genetics, with a 20% mortality rate mainly due to sepsis.

Melanin and melanocytes contribute to the brown pigmentation in stasis dermatitis.

Lichen planopilaris and frontal fibrosing alopecia are likely the same disease with different clinical appearances.

Despite progress in treatment, the exact cause of Alopecia areata is still unknown.

The article suggests that targeting specific immune pathways could help control and treat the skin disease hidradenitis suppurativa.

Some postmenopausal women with frontal fibrosing alopecia stopped losing hair with finasteride treatment, hinting at a possible hormonal cause.

Alopecia areata causes hair loss, has no cure, and various treatments exist.

Restoring hair bulb immune privilege is crucial for managing alopecia areata.

Graft-versus-host disease is a complication where donor immune cells attack the recipient's body, often affecting the skin, liver, and gastrointestinal tract.

The document concludes that primary scarring alopecias cause permanent hair loss, have unpredictable outcomes, and lack definitive treatments, requiring personalized care.

Some patients receiving pegylated interferon alfa injections developed skin necrosis, requiring treatment adjustments or discontinuation.

Permanent hair loss after bone marrow transplant can be caused by chemotherapy or chronic graft-versus-host disease.

The conclusion is that primary scarring alopecia is a complex condition that requires early and accurate diagnosis for effective treatment.

Combining skin tissue pathology with genetics has greatly improved the diagnosis and understanding of certain skin diseases.

Early diagnosis and combination therapy, especially with finasteride and dutasteride, are key to managing Frontal Fibrosing Alopecia effectively.

A woman's hair loss, resembling an autoimmune condition, improved after treatment, but requires ongoing checks due to potential serious associations.

The author clarifies that alopecia areata incognito and diffuse alopecia areata are different types of hair loss with unique symptoms and challenges in diagnosis.

Two young cats with a severe ear and skin condition improved with immune system-targeting treatments.

Examining nail biopsies is useful for diagnosing nail diseases.

Discoid Lupus Erythematosus often causes scarring hair loss, is influenced by genetics and environment, and requires early treatment to prevent worsening.

Peripilar signs can help diagnose androgenetic alopecia and reveal its cause.

Estrogen and prolactin may play bigger roles in female hair loss than previously thought.

Finasteride causes reduced tear flow and severe eye inflammation.

Increased HIF-1α is linked to the inflammation and severity of hidradenitis suppurativa, suggesting treatments that lower HIF-1α could help.

EPDS and MS might share an immune-related cause.

Inflammation and fibrosis are important factors in hair loss, but more research with better control samples is needed.